logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Mats Jerkeman

Lund University
H指数:50
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term survival and cause-specific mortality after event-free survival at 24 months (EFS24) in mantle cell lymphoma: an international multicohort study

套细胞淋巴瘤在24个月无事件生存期（EFS24）后的长期生存和特定病因死亡率：一项国际多队列研究

Blood Cancer Journal
IF11.6
2026-09-220
OAAI
Yucai Wang; Melissa C. Larson; Umar Farooq; Sara Ekberg; Karin E. Smedby; Mikkel R. Simonsen; Peter de Nully Brown; Carsten U. Niemann; Eric J. Zhao; Alina S. Gerrie; Jeffrey M. Switchenko; David A. Bond; Veronika Bachanova; Stefan K. Barta; Brian T. Hill; Peter Martin; Alexey V. Danilov; Natalie S. Grover; Reem Karmali; Nilanjan Ghosh; Timothy S. Fenske; Brad S. Kahl; Alexandra Albertsson-Lindblad; Ingrid Glimelius; Ahmed Ludvigsen Al-Mashhadi; Thomas S. Larsen; Kami J. Maddocks; Eric Mou; Jonas Paludo; Grzegorz S. Nowakowski; Thomas M. Habermann; Matthew J. Maurer; Diego Villa; Jonathon B. Cohen; Tarec C. El-Galaly; Mats Jerkeman; James R. Cerhan
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18–65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network

将自体干细胞移植加入含ibrutinib的一线治疗中，用于18-65岁套细胞淋巴瘤患者（TRIANGLE）：欧洲MCL网络三臂、随机、开放标签、Ⅲ期优效性试验4.5年随访

The Lancet
IF88.5
2026-05-140
OAAI
Martin Dreyling; Jeanette Doorduijn; Eva Giné; Mats Jerkeman; Jan Walewski; Martin Hutchings; Ulrich Mey; Jon Riise; Marek Trneny; Vibeke K J Vergote; Ofer Shpilberg; Maria Gomes da Silva; Sirpa Leppä; Linmiao Jiang; Stephan Stilgenbauer; Andrea Kerkhoff; Ron D Jachimowicz; Georg Heß; Tom van Meerten; Stefan Wirths
EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma

EHA–EU MCL网络关于套细胞淋巴瘤诊断与治疗指南

HemaSphere
IF14.6
2025-10-220
OAAI
Mats Jerkeman; Igor Aurer; Elias Campo; Chan Y. Cheah; Jonathan Clark; Jeanette Doorduijn; Toby A. Eyre; Martin Fehr; Eva Giné; Maria Gomes da Silva; Pavel Klener; Marco Ladetto; Vincent Ribrag; Ofer Shpilberg; Jan Walewski; Martin Dreyling; the EHA Guidelines Committee and the European MCL Network
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial

伊布替尼和利妥昔单抗对比免疫化疗用于初治套细胞淋巴瘤患者的随机、开放标签、II/III期优效性试验（ENRICH）

The Lancet
IF97.3
2025-10-030
OAAI
David J Lewis; Mats Jerkeman; Lexy Sorrell; David Wright; Ingrid Glimelius; Christian B Poulsen; Annika Pasanen; Andrew Rawstron; Karin F Wader; Nick Morley; Catherine Burton; Andrew J Davies; Ingemar Lagerlöf; Surita Dalal; Ruth De Tute; Chris McNamara; Nicola Crosbie; Helle Erbs Toldbod; Jeanette Sanders; Victoria Allgar; Sree Aroori; Mark Warner; Claire Scully; Brian Wainman; Jacob Haaber Christensen; Jon Riise; Kristina Sonnevi; Mark J Bishton; Toby A Eyre; Simon Rule
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial

IELSG37试验中免疫化疗方案对原发性纵隔B细胞淋巴瘤患者预后的影响

Blood
IF23.1
2025-09-150
PRE
Emanuele Zucca; Luca Ceriani; Giovannino Ciccone; Alice Di Rocco; Maria Cristina Pirosa; Iryna Kriachok; Barbara Botto; Monica Balzarotti; Alessandra Tucci; Sara Veronica Usai; Vittorio Ruggero Zilioli; Elsa Pennese; Luca Arcaini; Anna Dabrowska-Iwanicka; Andrés JM Ferreri; Francesco Merli; Weili Zhao; Luigi Rigacci; Claudia Cellini; David Hodgson; Codruta Ionescu; Carla Minoia; Elisa Lucchini; Michele Spina; Alexander Fosså; Andrea Janikova; Kate Cwynarski; N George Mikhaeel; Mats Jerkeman; Anastasios Stathis; Kelly Cozens; Nicoletta Ielmini; Iolanda De Martino; Jan Walewski; Marek Trneny; Franco Cavalli; Umberto Ricardi; Peter WM Johnson; Andrew Davies; Maurizio Martelli
Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma

循环肿瘤DNA在复发/难治性套细胞淋巴瘤中的应答和结局预测因素

Blood Advances
IF7.1
2025-05-270
OAAI
Leo Meriranta; Rasmus Rask Kragh Jørgensen; Annika Pasanen; Arne Kolstad; Martin Hutchings; Carsten Utoft Niemann; Tarec Christoffer El-Galaly; Jon Riise; Jacob Haaber Christensen; Kristina Sonnevi; Lone Bredo Pedersen; Karin Fahl Wader; Ingrid Glimelius; Sirpa Leppä; Mats Jerkeman
Aberrant Cytoplasmic Expression of p16 Is a New Strong Prognostic Marker in Young MCL Patients Treated By Frontline Cytarabine-Based Immunochemotherapy, a Study from the Lysa Group, Nordic Lymphoma Group and the European MCL Network

p16的异常细胞质表达是接受一线阿糖胞苷为基础的免疫化疗的年轻MCL患者的一个新的强预后标志物，一项来自Lysa Group、Nordic Lymphoma Group和European MCL Network的研究

BLOOD
IF23.1
2024-11-050
PRE
Le Bris, Yannick; Burroni, Barbara; Fournier, Marguerite; Cheminant, Morgane; Ek, Sara; Hoster, Eva; Delfau-Larue, Marie-Helene; Sarkozy, Clementine; Callanan, Mary B.; Tessoulin, Benoit; Chiron, David; Dreyling, Martin; Jerkeman, Mats; Le Gouill, Steven; Hermine, Olivier
Impact of Rituximab Maintenance Added to Ibrutinib-Containing Regimens with and without ASCT in Younger, Previously Untreated MCL Patients: An Analysis of the Triangle Data Embedded in the Multiply Project

利妥昔单抗维持治疗联合含伊布替尼方案（含或不含ASCT）对年轻、初治套细胞淋巴瘤患者的影响：一项来自Multiply项目嵌入Triangle数据集的分析

BLOOD
IF23.1
2024-11-053
PRE
Ladetto, Marco; Gutmair, Katja; Doorduijn, Jeanette K.; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke K. J.; Stefani, Piero Maria; Horowitz, Netanel A.; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Pott, Christiane; Klapper, Wolfram; Schmidt, Christian; Unterhalt, Michael; Dreyling, Martin; Hoster, Eva
Role of Autologous Stem Cell Transplantation in the Context of Ibrutinib-Containing First-Line Treatment in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network

自体干细胞移植在含伊布替尼的一线治疗背景下年轻套细胞淋巴瘤患者中的作用：欧洲MCL网络随机Triangle试验结果

BLOOD
IF23.1
2024-11-051
PRE
Dreyling, Martin; Doorduijn, Jeanette K.; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke K. J.; Donnarumma, Daniela; Shpilberg, Ofer; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Pott, Christiane; Klapper, Wolfram; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco; Hoster, Eva
Ibrutinib-Rituximab Is Superior to Rituximab-Chemotherapy in Previously Untreated Older Mantle Cell Lymphoma Patients: Results from the International Randomised Controlled Trial, Enrich

Ibrutinib-Rituximab方案优于Rituximab-化疗方案，用于初治老年套细胞淋巴瘤患者：国际随机对照试验Enrich的研究结果

BLOOD
IF23.1
2024-11-053
PRE
Lewis, David John; Jerkeman, Mats; Sorrell, Lexy; Wright, David; Glimelius, Ingrid; Pasanen, Annika; Christensen, Jacob Haaber; Wader, Karin Fahl; Davies, Andrew J.; Morley, Nick; Mcnamara, Christopher; Poulsen, Christian Bjorn; Riise, Jon; Sonnevi, Kristina; Lagerloef, Ingemar; Burton, Cathy; Dalal, Surita; Rawstron, Andrew; Tute, Ruth M. de; Allgar, Victoria; Aroori, Sree; Warner, Mark; Wainman, Brian; Scully, Claire; Sanders, Jeanette; Niemann, Carsten Utoft; Toldbod, Helle; Crosbie, Nicola; Bishton, Mark J.; Eyre, Toby A.; Rule, Simon
Comparing visual inspection with acetic acid, with and without Lugol's Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trial

比较乙酸视觉检查与使用或不使用Lugol's Iodine进行HPV自采样阳性女性分诊的随机对照试验

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2024-11-010
OAAI
Mekuria, Selamawit Fisseha; Biazin, Habtamu; Abebe, Tamrat; Borgfeldt, Christer; Assegid, Nahom; Mihret, Adane; Nemomsa, Reta Obsi; Forslund, Ola; Jerkeman, Mats

研究方向

暂未获取到该数据
I
Ingrid Glimelius
H 指数:38论文数:328被引数:5,363
K
Karin E. Smedby
H 指数:17论文数:70被引数:1,361
S
Sara Ek
H 指数:26论文数:158被引数:2,647
A
Arne Kolstad
H 指数:41论文数:228被引数:7,726
S
Sara Ekberg
H 指数:18论文数:97被引数:842
S
Sirpa Leppä
H 指数:50论文数:517被引数:1.1万
K
Kirsten Grønbæk
H 指数:55论文数:395被引数:1.0万
R
Riikka Räty
H 指数:26论文数:108被引数:3,081
M
Martin Dreyling
H 指数:83论文数:706被引数:3.2万
C
Christian Winther Eskelund
H 指数:16论文数:60被引数:1,350